{
    "summary":  {
                    "byStage":  {
                                    "stage1":  3,
                                    "stage2":  12,
                                    "stage3":  8
                                },
                    "dealCount":  23,
                    "byRegion":  {
                                     "europe":  3,
                                     "west":  4,
                                     "east":  16
                                 },
                    "totalAmount":  6721410,
                    "totalEgp":  2604540
                },
    "extractedAt":  "2026-02-05T23:19:15Z",
    "source":  "Sales MCP - get_open_pipeline_deals",
    "quarter":  "Q1 2026",
    "deals":  [
                  {
                      "owner":  "Vega Finucan",
                      "id":  "deal-001",
                      "accountName":  "Takeda Pharmaceuticals",
                      "stage":  2,
                      "opportunityId":  "006Vo00000qORIwIAO",
                      "stageName":  "2 Qualifying Opportunity",
                      "opportunityName":  "Takeda Data Scientist",
                      "egp":  50000,
                      "amount":  200000,
                      "reviewed":  false,
                      "region":  "east",
                      "forecastCategory":  "Pipeline",
                      "createdDate":  "2025-10-03",
                      "daysOpen":  125,
                      "daysInStage":  45,
                      "closeDate":  "2026-01-31"
                  },
                  {
                      "owner":  "Jim Macdonell",
                      "id":  "deal-002",
                      "accountName":  "J\u0026J MedTech",
                      "stage":  2,
                      "opportunityId":  "006Vo00000CuO0jIAF",
                      "stageName":  "2 Qualifying Opportunity",
                      "opportunityName":  "J\u0026J Medtech Labvantage Implementation",
                      "egp":  90000,
                      "amount":  200000,
                      "reviewed":  false,
                      "region":  "east",
                      "forecastCategory":  "Pipeline",
                      "createdDate":  "2024-11-12",
                      "daysOpen":  450,
                      "daysInStage":  45,
                      "closeDate":  "2026-03-13"
                  },
                  {
                      "owner":  "Mike Campbell",
                      "id":  "deal-003",
                      "accountName":  "Halozyme, Inc.",
                      "stage":  1,
                      "opportunityId":  "006Vo00000Lpnx7IAB",
                      "stageName":  "1 Sourcing The Lead",
                      "opportunityName":  "Haloyzyme ERP Validation and Cloud Assurance",
                      "egp":  90000,
                      "amount":  200000,
                      "reviewed":  false,
                      "region":  "west",
                      "forecastCategory":  "Pipeline",
                      "createdDate":  "2025-03-07",
                      "daysOpen":  335,
                      "daysInStage":  45,
                      "closeDate":  "2026-03-31"
                  },
                  {
                      "owner":  "Marcus Dinan",
                      "id":  "deal-004",
                      "accountName":  "Windward Bio AG",
                      "stage":  3,
                      "opportunityId":  "006Vo00001C7yOEIAZ",
                      "stageName":  "3 Developing And Presenting Solution",
                      "opportunityName":  "EU-Windward Bio- Microsoft Data Management \u0026 Azure Active Directory",
                      "egp":  81700,
                      "amount":  204250,
                      "reviewed":  false,
                      "region":  "europe",
                      "forecastCategory":  "Pipeline",
                      "createdDate":  "2026-01-28",
                      "daysOpen":  8,
                      "daysInStage":  8,
                      "closeDate":  "2026-03-27"
                  },
                  {
                      "owner":  "Lisa Burgese Fry",
                      "id":  "deal-005",
                      "accountName":  "Abbott Laboratories Pacific",
                      "stage":  3,
                      "opportunityId":  "006Vo00000zlT9tIAE",
                      "stageName":  "3 Developing And Presenting Solution",
                      "opportunityName":  "Abbott ProcessX Impact Assessment and DoEO",
                      "egp":  88664,
                      "amount":  221660,
                      "reviewed":  false,
                      "region":  "east",
                      "forecastCategory":  "Pipeline",
                      "createdDate":  "2025-11-17",
                      "daysOpen":  80,
                      "daysInStage":  45,
                      "closeDate":  "2026-03-20"
                  },
                  {
                      "owner":  "Mike Campbell",
                      "id":  "deal-006",
                      "accountName":  "Cytokinetics, Inc.",
                      "stage":  2,
                      "opportunityId":  "006Vo00000yTP8iIAG",
                      "stageName":  "2 Qualifying Opportunity",
                      "opportunityName":  "Cytokinetics  Technical And Validation",
                      "egp":  50000,
                      "amount":  200000,
                      "reviewed":  false,
                      "region":  "west",
                      "forecastCategory":  "Pipeline",
                      "createdDate":  "2025-11-10",
                      "daysOpen":  87,
                      "daysInStage":  45,
                      "closeDate":  "2026-02-28"
                  },
                  {
                      "owner":  "Mike Campbell",
                      "id":  "deal-007",
                      "accountName":  "Nektar Therapeutics",
                      "stage":  2,
                      "opportunityId":  "006Vo0000132CMDIA2",
                      "stageName":  "2 Qualifying Opportunity",
                      "opportunityName":  "Nektar Clinical Supply Management",
                      "egp":  50000,
                      "amount":  200000,
                      "reviewed":  false,
                      "region":  "west",
                      "forecastCategory":  "Pipeline",
                      "createdDate":  "2025-12-05",
                      "daysOpen":  62,
                      "daysInStage":  45,
                      "closeDate":  "2026-02-28"
                  },
                  {
                      "owner":  "Jim Macdonell",
                      "id":  "deal-008",
                      "accountName":  "Integra Lifesciences Holdings Corporation",
                      "stage":  2,
                      "opportunityId":  "006Vo00001D1g3dIAB",
                      "stageName":  "2 Qualifying Opportunity",
                      "opportunityName":  "Regulatory Specialist 2-2026",
                      "egp":  62500,
                      "amount":  250000,
                      "reviewed":  false,
                      "region":  "east",
                      "forecastCategory":  "Pipeline",
                      "createdDate":  "2026-02-02",
                      "daysOpen":  3,
                      "daysInStage":  3,
                      "closeDate":  "2026-02-27"
                  },
                  {
                      "owner":  "Vega Finucan",
                      "id":  "deal-009",
                      "accountName":  "Takeda Pharmaceuticals",
                      "stage":  2,
                      "opportunityId":  "006Vo00001A8WnfIAF",
                      "stageName":  "2 Qualifying Opportunity",
                      "opportunityName":  "Takeda - 2 JDE C2C resources",
                      "egp":  50000,
                      "amount":  200000,
                      "reviewed":  false,
                      "region":  "east",
                      "forecastCategory":  "Pipeline",
                      "createdDate":  "2026-01-16",
                      "daysOpen":  20,
                      "daysInStage":  20,
                      "closeDate":  "2026-02-06"
                  },
                  {
                      "owner":  "Michelle Dias",
                      "id":  "deal-010",
                      "accountName":  "Bristol-Myers Squibb Company",
                      "stage":  2,
                      "opportunityId":  "006Vo00000o0nNQIAY",
                      "stageName":  "2 Qualifying Opportunity",
                      "opportunityName":  "BMS ProcessX Moda Change Control",
                      "egp":  112500,
                      "amount":  250000,
                      "reviewed":  false,
                      "region":  "east",
                      "forecastCategory":  "Pipeline",
                      "createdDate":  "2025-09-19",
                      "daysOpen":  140,
                      "daysInStage":  45,
                      "closeDate":  "2026-02-28"
                  },
                  {
                      "owner":  "Mike Campbell",
                      "id":  "deal-011",
                      "accountName":  "Ionis Pharmaceuticals, Inc.",
                      "stage":  3,
                      "opportunityId":  "006Vo00000kBJhZIAW",
                      "stageName":  "4 Gaining Commitment",
                      "opportunityName":  "Ionis_AI Inspection Readiness MVP - SOW25",
                      "egp":  83920,
                      "amount":  209800,
                      "reviewed":  false,
                      "region":  "west",
                      "forecastCategory":  "Commit",
                      "createdDate":  "2025-08-26",
                      "daysOpen":  163,
                      "daysInStage":  45,
                      "closeDate":  "2026-02-13"
                  },
                  {
                      "owner":  "Josh Ertmer",
                      "id":  "deal-012",
                      "accountName":  "Takeda Pharmaceuticals",
                      "stage":  3,
                      "opportunityId":  "006Vo00001CgDvwIAF",
                      "stageName":  "4 Gaining Commitment Staffing",
                      "opportunityName":  "5535-Takeda Labware Phase III (A Nallaswami)",
                      "egp":  78416,
                      "amount":  301600,
                      "reviewed":  false,
                      "region":  "east",
                      "forecastCategory":  "Commit",
                      "createdDate":  "2026-01-30",
                      "daysOpen":  6,
                      "daysInStage":  6,
                      "closeDate":  "2026-02-27"
                  },
                  {
                      "owner":  "Lisa Burgese Fry",
                      "id":  "deal-013",
                      "accountName":  "Supernus Pharmaceuticals, Inc.",
                      "stage":  2,
                      "opportunityId":  "006Vo000010RfMmIAK",
                      "stageName":  "2 Qualifying Opportunity",
                      "opportunityName":  "Supernus Servicenow ITSM implementation \u0026 licenses",
                      "egp":  112500,
                      "amount":  250000,
                      "reviewed":  false,
                      "region":  "east",
                      "forecastCategory":  "Pipeline",
                      "createdDate":  "2025-11-20",
                      "daysOpen":  77,
                      "daysInStage":  45,
                      "closeDate":  "2026-03-06"
                  },
                  {
                      "owner":  "Scott Pallardy",
                      "id":  "deal-014",
                      "accountName":  "Arthrex",
                      "stage":  2,
                      "opportunityId":  "006Vo00000VI0vqIAD",
                      "stageName":  "2 Qualifying Opportunity",
                      "opportunityName":  "Arthrex - CDMS Implementation and Validation",
                      "egp":  112500,
                      "amount":  250000,
                      "reviewed":  false,
                      "region":  "east",
                      "forecastCategory":  "Pipeline",
                      "createdDate":  "2025-05-27",
                      "daysOpen":  254,
                      "daysInStage":  45,
                      "closeDate":  "2026-03-31"
                  },
                  {
                      "owner":  "Marcus Dinan",
                      "id":  "deal-015",
                      "accountName":  "Basilea Pharmaceutica International Ltd. Allschwil",
                      "stage":  3,
                      "opportunityId":  "006Vo00000EFqpUIAT",
                      "stageName":  "3 Developing And Presenting Solution",
                      "opportunityName":  "EU-Basilea-Managed Services",
                      "egp":  111760,
                      "amount":  279400,
                      "reviewed":  false,
                      "region":  "europe",
                      "forecastCategory":  "Pipeline",
                      "createdDate":  "2024-12-10",
                      "daysOpen":  422,
                      "daysInStage":  45,
                      "closeDate":  "2026-03-27"
                  },
                  {
                      "owner":  "Avani Macwan",
                      "id":  "deal-016",
                      "accountName":  "Bausch Health US, LLC",
                      "stage":  3,
                      "opportunityId":  "006Vo000011CFv7IAG",
                      "stageName":  "3 Developing And Presenting Solution",
                      "opportunityName":  "5409-Bausch Health GLIMS Platform: Deployment \u0026 Operations-CR2",
                      "egp":  185080,
                      "amount":  462700,
                      "reviewed":  false,
                      "region":  "east",
                      "forecastCategory":  "Pipeline",
                      "createdDate":  "2025-11-25",
                      "daysOpen":  72,
                      "daysInStage":  45,
                      "closeDate":  "2026-02-27"
                  },
                  {
                      "owner":  "Lisa Burgese Fry",
                      "id":  "deal-017",
                      "accountName":  "argenx BV",
                      "stage":  2,
                      "opportunityId":  "006Vo00001BwdtUIAR",
                      "stageName":  "2 Qualifying Opportunity",
                      "opportunityName":  "5408-Argenx Third Party Vendor Managed Services-CR2",
                      "egp":  144000,
                      "amount":  360000,
                      "reviewed":  false,
                      "region":  "east",
                      "forecastCategory":  "Pipeline",
                      "createdDate":  "2026-01-27",
                      "daysOpen":  9,
                      "daysInStage":  9,
                      "closeDate":  "2026-01-27"
                  },
                  {
                      "owner":  "Scott Pallardy",
                      "id":  "deal-018",
                      "accountName":  "BioCryst Pharmaceuticals, Inc.",
                      "stage":  3,
                      "opportunityId":  "006Vo00000lsoPmIAI",
                      "stageName":  "3 Developing And Presenting Solution",
                      "opportunityName":  "BioCryst - Cloud Assurance and Managed Services",
                      "egp":  127200,
                      "amount":  318000,
                      "reviewed":  false,
                      "region":  "east",
                      "forecastCategory":  "Best Case",
                      "createdDate":  "2025-09-05",
                      "daysOpen":  153,
                      "daysInStage":  45,
                      "closeDate":  "2026-03-31"
                  },
                  {
                      "owner":  "Scott Pallardy",
                      "id":  "deal-019",
                      "accountName":  "Biogen U.S. Corporation",
                      "stage":  3,
                      "opportunityId":  "006Vo000015DTwrIAG",
                      "stageName":  "3 Developing And Presenting Solution",
                      "opportunityName":  "Biogen - Global Audits RFP - 2026",
                      "egp":  450000,
                      "amount":  1000000,
                      "reviewed":  false,
                      "region":  "east",
                      "forecastCategory":  "Pipeline",
                      "createdDate":  "2025-12-17",
                      "daysOpen":  50,
                      "daysInStage":  45,
                      "closeDate":  "2026-03-13"
                  },
                  {
                      "owner":  "Hovsep Kirikian",
                      "id":  "deal-020",
                      "accountName":  "Kailera Therapeutics",
                      "stage":  2,
                      "opportunityId":  "006Vo00000tdihRIAQ",
                      "stageName":  "2 Qualifying Opportunity",
                      "opportunityName":  "Kailera - 2026 MSP Support",
                      "egp":  180000,
                      "amount":  400000,
                      "reviewed":  false,
                      "region":  "east",
                      "forecastCategory":  "Pipeline",
                      "createdDate":  "2025-10-20",
                      "daysOpen":  108,
                      "daysInStage":  45,
                      "closeDate":  "2026-01-30"
                  },
                  {
                      "owner":  "Sherry De Luca",
                      "id":  "deal-021",
                      "accountName":  "Ironwood Pharmaceuticals",
                      "stage":  1,
                      "opportunityId":  "006Vo00000RSzLxIAL",
                      "stageName":  "1 Sourcing The Lead",
                      "opportunityName":  "Ironwood - CRO Assurance",
                      "egp":  118800,
                      "amount":  264000,
                      "reviewed":  false,
                      "region":  "east",
                      "forecastCategory":  "Pipeline",
                      "createdDate":  "2025-04-28",
                      "daysOpen":  283,
                      "daysInStage":  45,
                      "closeDate":  "2026-02-11"
                  },
                  {
                      "owner":  "Kim Guihen",
                      "id":  "deal-022",
                      "accountName":  "AEROGEN LIMITED",
                      "stage":  1,
                      "opportunityId":  "006Vo00001Cd0tZIAR",
                      "stageName":  "1 Sourcing The Lead",
                      "opportunityName":  "Aerogen Oracle SCM Cloud Assurance",
                      "egp":  112500,
                      "amount":  250000,
                      "reviewed":  false,
                      "region":  "europe",
                      "forecastCategory":  "Pipeline",
                      "createdDate":  "2026-01-30",
                      "daysOpen":  6,
                      "daysInStage":  6,
                      "closeDate":  "2026-03-31"
                  },
                  {
                      "owner":  "Josh Ertmer",
                      "id":  "deal-023",
                      "accountName":  "Amgen Inc.",
                      "stage":  2,
                      "opportunityId":  "006Vo00001DWDRyIAP",
                      "stageName":  "2 Qualifying Opportunity",
                      "opportunityName":  "Amgen -Veeva QMS Implementation Consultant",
                      "egp":  62500,
                      "amount":  250000,
                      "reviewed":  false,
                      "region":  "east",
                      "forecastCategory":  "Pipeline",
                      "createdDate":  "2026-02-04",
                      "daysOpen":  1,
                      "daysInStage":  1,
                      "closeDate":  "2026-03-06"
                  }
              ]
}
